| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 05/06/2004 | EP1414471A2 Therapeutic agents comprising pro-apoptotic proteins |
| 05/06/2004 | EP1414406A2 A bioactive agent delivering system comprised of microparticules within a biodegradable to improve release profiles |
| 05/06/2004 | EP1226438B1 Composite nanospheres and their conjugates with biomolecules |
| 05/06/2004 | EP0812209B1 Cochleate delivery vehicles for biologically relevant molecules |
| 05/06/2004 | EP0776161B1 Use of a viral vector encoding a cytochrome p450 gene in combination with a chemotherapeutic agent for selectively destroying neoplastic cells |
| 05/06/2004 | CA2503164A1 Gpr54 knock-out mammals and screening methods using them |
| 05/06/2004 | CA2502960A1 Active specific immunotherapy of cancer metastasis |
| 05/06/2004 | CA2497913A1 Use of chimeric nucleases to stimulate gene targeting |
| 05/06/2004 | CA2468903A1 Endogenous retrovirus up-regulated in prostate cancer |
| 05/05/2004 | CN1494592A Nucleic acid expressed in hypothalamus or muscle tissue in obese animals |
| 05/05/2004 | CN1494588A Use of protein histidine phosphatase |
| 05/05/2004 | CN1494552A Flt 4 (VEGFR-3) as target for tumor imaging and anti-tumor therapy |
| 05/05/2004 | CN1148450C Recombinant proteinse of a Pakistani Strain of Hepatitis E and their use in diagnostic methods and vaccines |
| 05/05/2004 | CN1148446C Polypeptide bound with MORT-1 and MACH and its DNA sequence, producing method, medical composition and use |
| 05/05/2004 | CN1148228C Gene medicine for treating hemophilia B and its preparing process |
| 05/04/2004 | US6730781 Using ceramic hydroxyapatite column chromatography; avoids toxic organic solvents and animal enzymes, centrifugations, tedious precipitation |
| 05/04/2004 | US6730777 Cystic fibrosis gene |
| 05/04/2004 | US6730511 Vectors that repress heterologous promoter activity |
| 05/04/2004 | US6730507 Helper virus based on the ad2 and ad5 (adenovirus) serotype to produce genetically identical hdad (helper-dependent adenovirus) that differ only in the virion protein components ; for gene therapy, genetic vaccines |
| 05/04/2004 | US6730480 Sphingosine kinase enzyme |
| 05/04/2004 | US6730476 Methods of diagnosing early-onset menopause |
| 05/04/2004 | US6730328 Stable protein and nucleic acid formulations using non-aqueous, anhydrous, aprotic, hydrophobic, non-polar vehicles with low reactivity |
| 05/04/2004 | US6730324 Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation |
| 05/04/2004 | US6730303 Fused G-CSF and IL-3 proteins and uses thereof |
| 05/04/2004 | US6730297 Use of recombinant gene delivery vectors for treating or preventing lysosomal storage disorders |
| 04/30/2004 | CA2450643A1 Methods of diagnosing, preventing, and treating early onset of pulmonary hypertension |
| 04/29/2004 | WO2004036221A2 Compositions and methods for diagnosing and treating autoimmune disease |
| 04/29/2004 | WO2004035796A1 Expressional enhancers from viruses |
| 04/29/2004 | WO2004035789A1 Gene families associated with cancers |
| 04/29/2004 | WO2004035787A2 Transplantable cell with immune modulator |
| 04/29/2004 | WO2004035779A1 Biomolecule transfer method using virus envelope and composition and system therefor |
| 04/29/2004 | WO2004035777A1 Adipocyte differentiation-associated genes and proteins |
| 04/29/2004 | WO2004035774A2 Expression vectors for selection from stem cells of differentiated cardiomyocytes |
| 04/29/2004 | WO2004035676A2 Antisense modulation of notch (drosophila) homolog 4 expression |
| 04/29/2004 | WO2004035616A2 Adenovirus expressing genes in reverse order and use thereof |
| 04/29/2004 | WO2004035611A2 Peptides binding the phosphatase 2a protein and polynucleotides encoding same |
| 04/29/2004 | WO2004035088A1 Therapeutics/diagnostics for brain tumor |
| 04/29/2004 | WO2004035082A2 Proteins involved in the regulation of energy homeostasis |
| 04/29/2004 | WO2004035006A2 Methods and compositions for immunization against hiv |
| 04/29/2004 | WO2004034995A2 Methods and reagents for inducing immunity |
| 04/29/2004 | WO2004034966A2 Substances for preventing and treating autoimmune diseases |
| 04/29/2004 | WO2004034780A2 Method of producing recombinant proteins in the mammary gland of non-transgenic mammals |
| 04/29/2004 | WO2004016151A3 Pthrp-derived modulators of smooth muscle proliferation |
| 04/29/2004 | WO2004014311A3 Nogo receptor antagonists |
| 04/29/2004 | WO2004012732A3 Use of a proteasome inhibitor in the treatment of endothelial dysfunction and/or in a low-dose proteasome inhibitor therapy |
| 04/29/2004 | WO2004007770A3 Method for diagnosis of intestinal-type gastric tumors |
| 04/29/2004 | WO2004003185A3 Plant deoxyribonucleoside kinase enzymes and their use |
| 04/29/2004 | WO2003104485A3 Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue |
| 04/29/2004 | WO2003104392A9 Improved reagents and methods for producing parvoviruses |
| 04/29/2004 | WO2003087408A3 Schizophrenia associated genes |
| 04/29/2004 | WO2003087368A3 Means and methods for the specific modulation of target genes in the cns and the eye and methods for their identification |
| 04/29/2004 | WO2003087367A3 Means and methods for the specific inhibition of genes in cells and tissue of the cns and/or eye |
| 04/29/2004 | WO2003060147A3 Method of obtaining purified enterochromaffin cells and methods of using same |
| 04/29/2004 | WO2003032913A9 Methods and compositions for targeting proteins across the blood brain barrier |
| 04/29/2004 | WO2003015612A9 Materials and methods to promote repair of nerve tissue |
| 04/29/2004 | WO2003012039A8 Targeting nucleic acids to a cellular nucleus |
| 04/29/2004 | WO2003004683A3 Nucleic acids encoding recombinant 56 and 82 kda antigens from gametocytes of eimeria maxima and their uses |
| 04/29/2004 | WO2003004517A3 Peyers's patch and/or m-celle targeting ligands |
| 04/29/2004 | WO2001079274A8 Tuberculosis antigens and methods of use thereof |
| 04/29/2004 | WO1999028440A9 Nucleic acid encoding mammalian ubr1 |
| 04/29/2004 | US20040083496 Genetic engineered polypeptides; incubation, amplification |
| 04/29/2004 | US20040082659 Enhancement of vascular function by modulation of endogenous nitric oxide production or activity |
| 04/29/2004 | US20040082535 Glucocerebrosidas DNA molecule having modification in one nucleotide that disrupts splicing consensus sequence and prevents splicing of mRNA produced from DNA molecule, while preserving ability of DNA to express glucocerebrosidas enzyme |
| 04/29/2004 | US20040082533 Electro-gene therapy of arthritis by using an expression plasmid encoding the soluble p75 tumor necrosis factor receptor-Fc fusion protein |
| 04/29/2004 | US20040082532 Antifungal therapeutic targets |
| 04/29/2004 | US20040082529 Treating or preventing cancer by administering to subject a vector comprising a heterologous polynucleotide operably linked to one or more regulatory sequences derived from an H19, IGF-1 or IGF-2 P4 transcriptional regulatory sequence |
| 04/29/2004 | US20040082515 Regulation of biological events using novel compounds |
| 04/29/2004 | US20040082507 Use of GLP-1 and GLP-2 peptides |
| 04/29/2004 | US20040082506 For treating hypophosphatemic rickets/osteomalacia/ osteoporosis/renal osteodystrophy/dialysis-associated bone diseases |
| 04/29/2004 | US20040082064 Stimulanting immunology response; calibrating success of organ, tissue transplant; polymerase chain reaction analysis; administering immunosuppressants |
| 04/29/2004 | US20040082037 Antiproliferative agents of vascular smooth muscles |
| 04/29/2004 | US20040082034 Stable hairpin structure; promoter joining to nucleotide sequence |
| 04/29/2004 | US20040082003 Stem cell expansion enhancing factor and method of use |
| 04/29/2004 | US20040081998 Novel carboxylesterase nucleic acid molecules, proteins and uses thereof |
| 04/29/2004 | US20040081982 Neocentromere-based mini-chromosomes or artificial chromosomes |
| 04/29/2004 | US20040081976 Genomic screen for epigenetically silenced tumor suppressor genes |
| 04/29/2004 | US20040081972 Detecting antibodies; screening, development therapies for infections, inflammation; polypeptides; monoclonal antibodies |
| 04/29/2004 | US20040081687 Cholesterol group is linked to the optional linker group via a carbamoyl linkage and then linked to carbohydrate |
| 04/29/2004 | US20040081637 Insertion target ligands into proteins; detection fluorescent signals; determination, calibration; gene therapy; antitumor agents |
| 04/29/2004 | US20040081636 Genetic engineering; polynucleotides |
| 04/29/2004 | DE10294485T5 Mit Mnk-Kinase homologe Proteine, die in die Regulation der Energiehomöostase und den Organellenmetabolismus involviert sind Mnk homologous proteins with kinase, that are involved in the regulation of energy homeostasis and the metabolism organelle |
| 04/29/2004 | CA2649821A1 Polynucleotide sequences encoding .delta.bcl-2 for preventing and treating autoimmune diseases |
| 04/29/2004 | CA2515650A1 New adenoviruses, nucleic acids coding therefor and their use |
| 04/29/2004 | CA2502902A1 Method of producing recombinant proteins in the mammary gland of non-transgenic mammals |
| 04/29/2004 | CA2502863A1 Expressional enhancers from viruses |
| 04/29/2004 | CA2502312A1 Transplantable cell with immune modulator |
| 04/29/2004 | CA2497313A1 Biomolecule transfer method using virus envelope and composition and system therefor |
| 04/28/2004 | EP1413314A1 Medicinal compositions |
| 04/28/2004 | EP1412757A2 Method for identification of proteins from intracellular bacteria |
| 04/28/2004 | EP1412754A1 Diagnostic methods and agents |
| 04/28/2004 | EP1412510A2 Aav vector packaging plasmid for producing wtaav particles or pseudotyped aav particles without helper viruses, by means of a single transfection |
| 04/28/2004 | EP1412509A2 Rna amplification system using plant components in animal cells |
| 04/28/2004 | EP1412503A2 A fusion protein |
| 04/28/2004 | EP1412498A2 Polynucleotides expressed in dendritic cells and polypeptides encoded thereby |
| 04/28/2004 | EP1412492A2 Regulator of calcineurin |
| 04/28/2004 | EP1412486A2 Method for virus propagation |
| 04/28/2004 | EP1412485A1 Antigen presenting cells, method for their preparation and their use for cancer vaccines |
| 04/28/2004 | EP1412482A2 Uses of opg ligand to modulate immune responses |
| 04/28/2004 | EP1412477A2 GPCs AS MODIFIERS OF THE IRRTK AND P21 PATHWAYS AND METHODS OF USE |
| 04/28/2004 | EP1412385A2 Modified insulin with reduced immunogenicity |